MiNK Therapeutics's total assets for Q1 2025 were $4.27M, a decrease of -25.41% from the previous quarter. INKT total liabilities were $26.06M for the fiscal quarter, a 2.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.